These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27628679)

  • 1. Reduction of Atherosclerotic Lesions by the Chemotherapeutic Agent Carmustine Associated to Lipid Nanoparticles.
    Daminelli EN; Martinelli AE; Bulgarelli A; Freitas FR; Maranhão RC
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):433-443. PubMed ID: 27628679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits.
    Bulgarelli A; Leite AC; Dias AA; Maranhão RC
    Cardiovasc Drugs Ther; 2013 Dec; 27(6):531-9. PubMed ID: 24065615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core Nanoparticles.
    Gomes FLT; Maranhão RC; Tavares ER; Carvalho PO; Higuchi ML; Mattos FR; Pitta FG; Hatab SA; Kalil-Filho R; Serrano CV
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):561-569. PubMed ID: 29779420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of atherosclerotic lesions in rabbits treated with etoposide associated with cholesterol-rich nanoemulsions.
    Tavares ER; Freitas FR; Diament J; Maranhão RC
    Int J Nanomedicine; 2011; 6():2297-304. PubMed ID: 22072867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model.
    Meneghini BC; Tavares ER; Guido MC; Tavoni TM; Stefani HA; Kalil-Filho R; Maranhão RC
    Vascul Pharmacol; 2019 Apr; 115():46-54. PubMed ID: 30797043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of combined chemotherapy with etoposide and methotrexate, both associated to lipid nanoemulsions for atherosclerosis treatment in cholesterol-fed rabbits.
    Leite AC; Solano TV; Tavares ER; Maranhão RC
    Cardiovasc Drugs Ther; 2015 Feb; 29(1):15-22. PubMed ID: 25672520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on Walker 256 tumour of carmustine associated with a cholesterol-rich microemulsion (LDE).
    Teixeira RS; Curi R; Maranhão RC
    J Pharm Pharmacol; 2004 Jul; 56(7):909-14. PubMed ID: 15233870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid core nanoparticles resembling low-density lipoprotein and regression of atherosclerotic lesions: effects of particle size.
    Freitas SCMP; Tavares ER; Silva BMO; Meneghini BC; Kalil-Filho R; Maranhão RC
    Braz J Med Biol Res; 2018 Jan; 51(3):1-8. PubMed ID: 29513883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease.
    Hungria VT; Latrilha MC; Rodrigues DG; Bydlowski SP; Chiattone CS; Maranhão RC
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):51-60. PubMed ID: 14574458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit.
    Maranhão RC; Tavares ER; Padoveze AF; Valduga CJ; Rodrigues DG; Pereira MD
    Atherosclerosis; 2008 Apr; 197(2):959-66. PubMed ID: 18289548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate associated to lipid core nanoparticles improves cardiac allograft vasculopathy and the inflammatory profile in a rabbit heart graft model.
    Fiorelli AI; Lourenço-Filho DD; Tavares ER; Carvalho PO; Marques AF; Gutierrez PS; Maranhão RC; Stolf NAG
    Braz J Med Biol Res; 2017 Aug; 50(10):e6225. PubMed ID: 28832763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients.
    Maranhão RC; Graziani SR; Yamaguchi N; Melo RF; Latrilha MC; Rodrigues DG; Couto RD; Schreier S; Buzaid AC
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):487-98. PubMed ID: 12107554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Drugs Carried in Lipid Nanoparticles in Coronary Disease of Rabbit Transplanted Heart.
    Barbieri LR; Lourenço-Filho DD; Tavares ER; Carvalho PO; Gutierrez PS; Maranhão RC; Stolf NAG
    Ann Thorac Surg; 2017 Aug; 104(2):577-583. PubMed ID: 28347533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits.
    Hirano T; Yamashita S; Takahashi M; Hashimoto H; Mori Y; Goto M
    Metabolism; 2016 Jun; 65(6):893-903. PubMed ID: 27173468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An artificial nanoemulsion carrying paclitaxel decreases the transplant heart vascular disease: a study in a rabbit graft model.
    Lourenço-Filho DD; Maranhão RC; Méndez-Contreras CA; Tavares ER; Freitas FR; Stolf NA
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1522-8. PubMed ID: 21458008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma.
    Lucas SR; Maranhão RC; Guerra JL; Coelho BM; Barboza R; Pozzi DH
    Vet Comp Oncol; 2015 Sep; 13(3):184-93. PubMed ID: 23615221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles.
    Shiozaki AA; Senra T; Morikawa AT; Deus DF; Paladino-Filho AT; Pinto IM; Maranhão RC
    Clinics (Sao Paulo); 2016 Aug; 71(8):435-9. PubMed ID: 27626473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats.
    Pepineli R; Santana AC; Silva FMO; Tavoni TM; Stolf NAG; Noronha IL; Maranhão RC
    J Pharm Pharmacol; 2021 Jul; 73(8):1092-1100. PubMed ID: 33950246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
    Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of atherosclerotic lesions in cholesterol-fed mice during treatment with paclitaxel in lipid nanoparticles: a magnetic resonance imaging study.
    D Lima A; Hua N; C Maranhão R; A Hamilton J
    J Biomed Res; 2017 Jan; 31(2):116-121. PubMed ID: 28808193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.